Brean Murray Carret & Co. Starts DexCom (DXCM) at Buy; Sensing a Better Year Ahead

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. BABA
7. SPCX
8. AVGO
9. HD
10. BJ

January 17, 2012 7:30 AM EST
Get Alerts DXCM Hot Sheet
Price: $92.34 +2.35%

Rating Summary:
    32 Buy, 7 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Brean Murray Carret & Co. initiates coverage on DexCom (NASDAQ: DXCM) with a Buy. PT $12.50.

Brean analyst says, "2011 was a challenging year for DexCom, as new product delays and softer-than-expected revenue growth resulted in a 32% decline in DXCM shares. While 2012 is not without challenges - even when assuming persistent macroeconomic headwinds and a lack of significant new product contributions near-term, we have high conviction that the company will grow product revenue 35% over the next 2 years - among the highest in small cap Med Tech."

For an analyst ratings summary and ratings history on DexCom click here. For more ratings news on DexCom click here.

Shares of DexCom closed at $10.01 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Brean Murray Carret & Co.